ViewPoints Interview: Marc Meachem Shares Insight on the ViiV’s 2021 Commitment to the Community

  • by

In an interview with PharmaShots, Marc Meachem, Head of US External Affairs at ViiV Healthcare shared his views on the company’s approach towards the community. He also shed light on the grants and funding received for the betterment of HIV patients. Shots: ViiV Healthcare is… Read More »ViewPoints Interview: Marc Meachem Shares Insight on the ViiV’s 2021 Commitment to the Community

Analysis Estimates 5.1 Million People Fall into the Affordable Care Act’s “Family Glitch”

  • by

A new KFF analysis estimates 5.1 million people nationally fall into the Affordable Care Act’s “family glitch” that occurs when a worker receives an offer of affordable employer coverage for themselves but not for their dependents, making them ineligible for financial assistance for marketplace coverage.… Read More »Analysis Estimates 5.1 Million People Fall into the Affordable Care Act’s “Family Glitch”

Getting Vaccinated

  • by

So as I mentioned on Twitter yesterday, I’ve now had my first coronavirus vaccine dose (Pfizer/BioNTech). Since I’ve been writing about the mRNA vaccines for months here and cheering on the vaccine efforts in general, I can tell you that I’m very, very happy to… Read More »Getting Vaccinated

Novartis Collaborates with Artios Pharma to Discover Next Generation DDR Cancer Therapies

  • by

Shots: Artios to receive $20M upfront in addition to near term research funding to support the collaboration and is eligible to receive $1.3B in discovery, development, regulatory, and sales milestones along with royalties on net sales of products During the 3-yr collaboration, Artios and Novartis… Read More »Novartis Collaborates with Artios Pharma to Discover Next Generation DDR Cancer Therapies

J&J Vision Collaborates with Menicon to Offer Contact Lenses for Managing the Progression of Myopia in Children

  • by

Shots: Menicon to develop and manufacture contact lenses to help manage the progression of myopia in children. J&J Vision will focus on expanding the availability of these lenses across the globe The collaboration will combine the expertise of both the companies and allow J&J to… Read More »J&J Vision Collaborates with Menicon to Offer Contact Lenses for Managing the Progression of Myopia in Children

New group to tackle data governance and guide digital transformation in pharma

  • by

The Pistoia Alliance, a global, not-for-profit alliance advocating for greater collaboration in life sciences R&D, has launched its Data Governance Community of Interest (CoI). The CoI was set up after a roundtable discussion assessing industry priorities, attended by professionals from pharma companies such as AbbVie,… Read More »New group to tackle data governance and guide digital transformation in pharma

Targeting Overseas Tax Shelters

  • by

How one U.S. multinational used overseas shelters to slash its tax bill — and how the Biden administration plans to crack down on such practices.

Targeting Overseas Tax Shelters

  • by

How one U.S. multinational used overseas shelters to slash its tax bill — and how the Biden administration plans to crack down on such practices.

Beyond Reference Management: How Literature Management is a Win for the Life Science Organization

  • by

Scientific literature is a critical component to virtually all aspects of a life science enterprise, including Medical Affairs, Pharmacovigilance and R&D. However, the process of curating and sharing literature can lead to significant challenges in organizing content, facilitating collaboration and enforcing copyright compliance. In many… Read More »Beyond Reference Management: How Literature Management is a Win for the Life Science Organization

Progenity Signs an Agreement with Ionis Pharmaceuticals to Evaluate Oral Biotherapeutics Delivery System with Antisense Oligonucleotides

  • by

Shots: In the P-I study, the companies will evaluate the OBDS with Ionis’ drug for in vitro compatibility and performance as well as in vivo safety, tolerability, and performance in a preclinical canine model Progenity expects that the alliance could demonstrate the versatility of OBDS… Read More »Progenity Signs an Agreement with Ionis Pharmaceuticals to Evaluate Oral Biotherapeutics Delivery System with Antisense Oligonucleotides

Pear Sign a Multiple Agreements to Expands its Prescription Digital Therapeutic Platform

  • by

Shots: Pear collaborates with Empatica, etectRx and KeyWise to bolster its PDT platform with digital biomarkers, machine learning algorithms, sensor-based technologies, and digital therapeutics The new technologies complement its voice-based biomarkers previously licensed from Winterlight. The licensed technologies will facilitate the building of products for… Read More »Pear Sign a Multiple Agreements to Expands its Prescription Digital Therapeutic Platform

COVID-19 — stay up to date with the latest guidance and keep your workplace safe with OiRA tools

  • by

07/04/2021 COVID-19 — stay up to date with the latest guidance and keep your workplace safe with OiRA tools As our working environments and conditions change in response to the pandemic, it has never been more important to stay on top of workplace risk assessment.… Read More »COVID-19 — stay up to date with the latest guidance and keep your workplace safe with OiRA tools

Micro Labs Ltd- Walk-In Interviews for Quality Control/ Production On 10th April 2021

  • by

Micro Labs Ltd- Walk-In Interviews for Quality Control/ Production On 10th April 2021 Job Description Walk-In for Officer/ Executive/ Sr. Executive-Quality ControlRole and Responsibilities : Exposure to analysis of raw materials/ finished product/ In process. Materials/Stability/Method Validation. Exposure to regulated market shall be preferred.Experience: 3-7 years… Read More »Micro Labs Ltd- Walk-In Interviews for Quality Control/ Production On 10th April 2021

Dr. Reddy’s -Openings for Production/ Engineering Injectables Departments -Apply Now

  • by

Dr. Reddy’s -Openings for Production/ Engineering Injectables Departments -Apply Now Job Description Department: Production InjectableQualification: Diploma, B.E, B.Pharm, M.PharmExperience: 10 to 16 years Department: Engineering InjectableQualification: Diploma, B.E, B.TechExperience: 04 to 10 years Location:  Pydibhimavaram Candidates must send updated resume to reshmapotta@drreddys.com , along with Current CTC details by 15th April 2021, Shortlisted candidates… Read More »Dr. Reddy’s -Openings for Production/ Engineering Injectables Departments -Apply Now

‘Homecareist’ Vesta Raises $65M to Support Pop Health Programs, Risk-Based Contracts

  • by

Home-focused digital health platform Vesta Healthcare announced Tuesday it has raised an additional $65 million in growth capital. The New York City-based Vesta is a clinical provider and technology services organization that connects caregiver insights to the rest of an individual’s care team. As part… Read More »‘Homecareist’ Vesta Raises $65M to Support Pop Health Programs, Risk-Based Contracts

Diagnostic Errors Are More Common Than You Think

  • by

Diagnostic Errors Are More Common Than You Think Diagnostic mistakes are an under-appreciated source of patient safety errors, yet most of us will experience one in our lifetime. The Doctor Weighs In

Diagnostic Errors Are More Common Than You Think

  • by

Diagnostic Errors Are More Common Than You Think Diagnostic mistakes are an under-appreciated source of patient safety errors, yet most of us will experience one in our lifetime. The Doctor Weighs In

Bright Health acquires Zipnosis, enters telehealth market

  • by

Insurance technology startup Bright Health has purchased Zipnosis, which provides telehealth services. Though details of the new transaction are sparse, the acquisition aims to lower healthcare costs and expand access to quality care.

Senior Helpers Likely to Be the First of Many Home Care Dominoes to Fall in 2021

  • by

Last week, the investment arm of Advocate Aurora Health acquired Senior Helpers, the giant home care franchise organization that domestically operates across 44 states. Advocate Aurora Enterprises pulled the trigger on the Maryland-based Senior Helpers as part of its three-pronged investment thesis around aging, parenthood… Read More »Senior Helpers Likely to Be the First of Many Home Care Dominoes to Fall in 2021

Vaccination pace picks up steam; normality appears closer

  • by

The accelerating pace of vaccinations across the United States is offering hope that something close to normality is on the horizon.A significant taming of the pandemic in the U.S. could be just a matter of a few weeks, with an average 3…

Texas minors receive COVID-19 vaccine in error

  • by

More than a dozen minors in Texas received doses of the COVID-19 vaccine at a local hub site due to an error in the state’s waitlisting process.Dallas Emergency Manager Rocky Vaz sent a memo to Dallas’ city council and mayor on Monday detailing…

Biosimilars need a policy boost, experts say

  • by

Policies should align with patients’ and providers’ growing support of biosimilars, but the therapies’ adoption has been slowed by patent litigation and price manipulation, industry observers said.

California aims to reopen fully on June 15

  • by

California is planning to lift almost all coronavirus restrictions and fully open its economy on June 15, Gov. Gavin Newsom (D) said Tuesday.Newsom said he anticipates “an abundance” of vaccines from the federal government through the rest of April…

WHO does not support mandatory ‘vaccine passports’

  • by

The World Health Organization (WHO) does not currently support the use of “vaccine passports” for travel because of concerns of equity, an agency official said Tuesday.Mike Ryan, the executive director of the WHO’s emergencies program, said he’s…

Human testing underway for COVID-19 vaccine developed by Army

  • by

The U.S. Army began human testing on Tuesday for a COVID-19 vaccine that it developed, as researchers aim to increase the effectiveness of inoculation against several variants of the virus. The Walter Reed Army Institute of Research (WRAIR)…

FDA warns of infection risk from reusable urological endoscopes

  • by

The agency said it had received more than 450 reports of infections or other issues in the last four years from reprocessed urological endoscopes, which are used to view or access the urinary tract. Three patient deaths were associated with these infections. 

Cook County Health chair to step down

  • by

Hill Hammock, who served two terms on the board of one of the nation’s largest public health systems, plans to depart once his term ends in June.

White House rules out involvement in vaccine passports

  • by

White House press secretary Jen Psaki on Tuesday ruled out the Biden administration playing any role in a vaccine passport system as Republican governors in particular balk at the concept.”The government is not now, nor will we be…

EU expecting herd immunity by end of June: report

  • by

The European Commission says that most member states will have a sufficient coronavirus vaccine supply to reach herd immunity by the end of June, according to a memo circulated to national delegations in Brussels and viewed by Bloomberg.The…

Source of Zika neurodevelopmental defects

  • by

A study identified how microcephaly (abnormally small heads) and blindness may develop in Zika-infected fetuses, as well as a new way to potentially prevent these neurodevelopmental defects.

CDC distributes $3 billion for vaccine preparedness

  • by

 The Centers for Disease Control and Prevention is doling out more than $3.1 billion in federal funding under the last round of coronavirus relief legislation to help states and major cities administer vaccinations to their populations.In press…

Declines in Uncompensated Care Costs for The Uninsured under the ACA and Implications of Recent Growth in the Uninsured Rate

  • by

The increase in the uninsured rate in recent years, as well as loss of coverage during the pandemic, has led to attention on the consequences of being uninsured. The need for medical care to test, treat, or prevent COVID-19 has also highlighted the potential consequences… Read More »Declines in Uncompensated Care Costs for The Uninsured under the ACA and Implications of Recent Growth in the Uninsured Rate

Prostate Cancer: Symptoms, Tests, and Treatments

  • by

Prostate cancer is the most common cancer among men and the second most common cause of cancer-related deaths among American men. Learn more about the disease’s symptoms, tests, and treatments.

ViewPoints Interview: NeuBase Therapeutics’ Dietrich Stephan Shares Insight on its Approach to Genetic Medicine

  • by

In an interview with PharmaShots, Dietrich Stephan, Ph.D., CEO of NeuBase Therapeutics shared his views on the importance of preclinical in vivo data for PATrOL-enabled anti-gene for myotonic dystrophy type 1. Shots: NeuBase announced in vitro and in vivo data for its DM1 program, demonstrating… Read More »ViewPoints Interview: NeuBase Therapeutics’ Dietrich Stephan Shares Insight on its Approach to Genetic Medicine

Top Takeaways from the 2021 ONC Annual Meeting

  • by

ONC Leader Gives Health IT Vision  ONC’s newly appointed national coordinator Micky Tripathi introduced the 2021 ONC Annual Meeting by sharing his vision for the future of health IT strategy and policy throughout the healthcare system. He talked about the agency’s role in responding to the COVID-19 pandemic, striving for health equity through the use of health IT (he calls it “equity by design”), advancing interoperability of… Read More »Top Takeaways from the 2021 ONC Annual Meeting

Fauci tamps down fears of another coronavirus wave

  • by

Anthony Fauci, the nation’s top infectious diseases expert, on Tuesday said he is confident the mass vaccination effort underway in the United States will prevent another “explosion” of coronavirus cases and a fourth deadly wave of the pandemic.”As…

KFF/Post Survey Reveals the Serious Mental Health Challenges Facing Frontline Health Care Workers a Year into the COVID-19 Pandemic

  • by

About 1 in 6 Tested Positive for COVID-19, though Few Experienced Major Symptoms; Those Working in Nursing Homes or Assisted Living Facilities Most Likely to Report Testing Positive More than a year into the COVID-19 pandemic, a majority of frontline health care workers say the… Read More »KFF/Post Survey Reveals the Serious Mental Health Challenges Facing Frontline Health Care Workers a Year into the COVID-19 Pandemic

3rd Cell Engager Summit

  • by

With that in mind, the 3rd Cell Engager Summit (June 30 – July 1) is the only industry-led meeting focused on developing multi-specific cell engaging therapies in solid tumor indications, and accelerating early discovery innovation into the clinic. With over 32 world-class speakers set to share their ground-breaking insights, this… Read More »3rd Cell Engager Summit

Horizon Presents Results of Uplizna (inebilizumab-cdon) in N-MOmentum Trial for NMOSD at AAN 2021

  • by

Shots: The company reported the data from the N-MOmentum trial involves assessing Uplizna in patients with NMOSD The results from the N-MOmentum trial demonstrated a reduction in pain, long-term safety, and efficacy outcomes. Additional results from the new survey demonstrated NMOSD patient attitudes towards diagnosis… Read More »Horizon Presents Results of Uplizna (inebilizumab-cdon) in N-MOmentum Trial for NMOSD at AAN 2021

GSK Consumer Healthcare to incorporate paper bottles into its packaging

  • by

GlaxoSmithKline Consumer Healthcare (GSKCH) has joined the Pulpex paper bottle partner consortium and will explore incorporating recyclable paper bottles into its packaging. The partnership is part of GSKCH’s commitment for all consumer product packaging to be recyclable or reusable, including eliminating all problematic and unnecessary… Read More »GSK Consumer Healthcare to incorporate paper bottles into its packaging

Exelixis Reports the US FDA’s Acceptance of IND for XB002 in Patients with Advanced Solid Tumors

  • by

Shots: The US FDA has accepted IND to assess the safety, tolerability, PK, and preliminary antitumor activity of XB002 in patients with advanced solid tumors. The P-I trial is expected to initiate in Q2’21 The preclinical data demonstrated that XB002 binds to tissue factors without… Read More »Exelixis Reports the US FDA’s Acceptance of IND for XB002 in Patients with Advanced Solid Tumors

Medical schools push for action on gun violence

  • by

“We are a nation of contradictions, and sometimes what brings out the best in us also brings out the worst,” Drs. David Skorton and David A. Acosta wrote in a recent blog post on the Association of American Medical Colleges’ website.